{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:00:38Z","timestamp":1791489638509,"version":"4.3.4"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:00:00Z","timestamp":1788566400000},"content-version":"vor","delay-in-days":247,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000646","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000646","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP25K12383"],"award-info":[{"award-number":["JP25K12383"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101433","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:35:10Z","timestamp":1788881710000},"page":"101433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Griseofulvin as a dual-action agent against glioblastoma: anti-tumor effect and enhancement of 5-ALA photodynamic diagnosis in stem-like cells"],"prefix":"10.1016","volume":"49","author":[{"given":"Takayuki","family":"Nishiwaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urara","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Kuse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Shoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Takei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Egashira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Izumo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masamitsu","family":"Shimazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ctarc.2026.101433_bib0001","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1007\/s12672-025-03928-8","article-title":"Extent of reoperation predicts survival in recurrent IDH-wildtype glioblastoma based on institutional data and individual patient data meta analysis","volume":"16","author":"Basaran","year":"2025","journal-title":"Discov. Oncol."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101433_bib0002","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S1470-2045(06)70665-9","article-title":"ALA-glioma study group: fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial","volume":"7","author":"Stummer","year":"2006","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ctarc.2026.101433_bib0003","article-title":"Enhancement of 5-aminolevulinic acid-based fluorescence detection of side population-defined glioma stem cells by iron chelation","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ctarc.2026.101433_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2022.103119","article-title":"Ablation efficacy of 5-aminolevulinic acid-mediated photodynamic therapy on human glioma stem cells","volume":"41","author":"Omura","year":"2023","journal-title":"Photodiagnosis. Photodyn. Ther."},{"key":"10.1016\/j.ctarc.2026.101433_bib0005","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.894591","article-title":"Ferrochelatase: mapping the intersection of iron and porphyrin metabolism in the mitochondria","volume":"10","author":"Obi","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101433_bib0006","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1172\/JCI108787","article-title":"Comparative study of protoporphyrins in erythropoietic protoporphyria and griseofulvin-induced murine protoporphyria. Binding affinities, distribution, and fluorescence spectra in various blood fractions","volume":"60","author":"Poh-Fitzpatrick","year":"1977","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101433_bib0007","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1346-8138.1988.tb03654.x","article-title":"Griseofulvin-induced photodermatitis\u2212report of six cases","volume":"15","author":"Kojima","year":"1988","journal-title":"J. Dermatol."},{"issue":"28","key":"10.1016\/j.ctarc.2026.101433_bib0008","doi-asserted-by":"crossref","first-page":"9878","DOI":"10.1073\/pnas.0501821102","article-title":"Kinetic suppression of microtubule dynamic instability by griseofulvin: implications for its possible use in the treatment of cancer","volume":"102","author":"Panda","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101433_bib0009","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/1097-0215(200002)9999:9999<::AID-IJC1070>3.0.CO;2-#","article-title":"Griseofulvin potentiates antitumorigenesis effects of nocodazole through induction of apoptosis and G2\/M cell cycle arrest in human colorectal cancer cells","volume":"91","author":"Ho","year":"2001","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ctarc.2026.101433_bib0010","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/1471-2407-10-213","article-title":"Griseofulvin stabilizes microtubule dynamics, activates p53 and inhibits the proliferation of MCF-7 cells synergistically with vinblastine","volume":"10","author":"Rathinasamy","year":"2010","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101433_bib0011","first-page":"297","article-title":"Griseofulvin inhibits the growth of adrenocortical cancer cells in vitro","volume":"45","author":"Bramann","year":"2013","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.ctarc.2026.101433_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1459539","article-title":"Antitumor properties of griseofulvin and its toxicity","volume":"15","author":"Yu","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101433_bib0013","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"10.1016\/j.ctarc.2026.101433_bib0014","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1001\/jama.2017.18718","article-title":"Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial","volume":"318","author":"Stupp","year":"2017","journal-title":"JAMA J. Am. Med. Assoc."},{"issue":"Suppl 1","key":"10.1016\/j.ctarc.2026.101433_bib0015","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1093\/neuonc\/nov297","article-title":"American brain tumor association adolescent and young adult primary brain and central nervous system tumors diagnosed in the United States in 2008-2012","volume":"18 Suppl 1","author":"Ostrom","year":"2016","journal-title":"Neuro Oncol."},{"issue":"11","key":"10.1016\/j.ctarc.2026.101433_bib0016","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/jamaoncol.2016.1373","article-title":"Association of the extent of resection with survival in glioblastoma: a systematic review and meta-analysis","volume":"2","author":"Brown","year":"2016","journal-title":"JAMa Oncol."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101433_bib0017","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3171\/jns.2001.95.2.0190","article-title":"A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival","volume":"95","author":"Lacroix","year":"2001","journal-title":"J. Neurosurg."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101433_bib0018","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3171\/2011.2.JNS10998","article-title":"An extent of resection threshold for newly diagnosed glioblastomas","volume":"115","author":"Sanai","year":"2011","journal-title":"J. Neurosurg."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101433_bib0019","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1227\/NEU.0000000000000929","article-title":"What is the surgical benefit of utilizing 5-aminolevulinic acid for fluorescence-guided surgery of malignant gliomas?","volume":"77","author":"Hadjipanayis","year":"2015","journal-title":"Neurosurgery"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101433_bib0020","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1751-1097.1997.tb08549.x","article-title":"5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research","volume":"65","author":"Peng","year":"1997","journal-title":"Photochem. Photobiol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101433_bib0021","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1227\/NEU.0000000000000267","article-title":"Pichlmeier U: 5-aminolevulinic acid-derived tumor fluorescence: the diagnostic accuracy of visible fluorescence qualities as corroborated by spectrometry and histology and postoperative imaging","volume":"74","author":"Stummer","year":"2014","journal-title":"Neurosurgery"},{"issue":"7015","key":"10.1016\/j.ctarc.2026.101433_bib0022","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature03128","article-title":"Dirks PB: Identification of human brain tumour initiating cells","volume":"432","author":"Singh","year":"2004","journal-title":"Nature"},{"issue":"7120","key":"10.1016\/j.ctarc.2026.101433_bib0023","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nature05236","article-title":"Glioma stem cells promote radioresistance by preferential activation of the DNA damage response","volume":"444","author":"Bao","year":"2006","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101433_bib0024","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1046\/j.1471-4159.1996.67020838.x","article-title":"Demonstration and characterization of the iron regulatory protein in human brain","volume":"67","author":"Hu","year":"1996","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101433_bib0025","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1562\/2005-12-04-RA-745","article-title":"On the role of iron and one of its chelating agents in the production of protoporphyrin IX generated by 5-aminolevulinic acid and its hexyl ester derivative tested on an epidermal equivalent of human skin","volume":"82","author":"Uehlinger","year":"2006","journal-title":"Photochem. Photobiol."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101433_bib0026","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0006-8993(02)03749-6","article-title":"Transport of 5-aminolevulinic acid between blood and brain","volume":"959","author":"Ennis","year":"2003","journal-title":"Brain Res."},{"issue":"11","key":"10.1016\/j.ctarc.2026.101433_bib0027","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1093\/neuonc\/nor116","article-title":"Enhanced expression of coproporphyrinogen oxidase in malignant brain tumors: CPOX expression and 5-ALA-induced fluorescence","volume":"13","author":"Takahashi","year":"2011","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.ctarc.2026.101433_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115031","article-title":"Inhibition of ABCG2 transporter by lapatinib enhances 5-aminolevulinic acid-mediated protoporphyrin IX fluorescence and photodynamic therapy response in human glioma cell lines","volume":"200","author":"Mansi","year":"2022","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101433_bib0029","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/php.70057","article-title":"Combination of iron chelator deferoxamine and ABCG2 transporter inhibitor lapatinib for therapeutic enhancement of 5-aminolevulinic acid","volume":"102","author":"Olsen","year":"2025","journal-title":"Photochem. Photobiol."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101433_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216503","article-title":"ABCG2 expression is related to low 5-ALA photodynamic diagnosis (PDD) efficacy and cancer stem cell phenotype, and suppression of ABCG2 improves the efficacy of PDD","volume":"14","author":"Kawai","year":"2019","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.ctarc.2026.101433_bib0031","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1007\/s00432-022-04347-w","article-title":"C5\u03b1 secreted by tumor mesenchymal stem-like cells mediates resistance to 5-aminolevulinic acid-based photodynamic therapy against glioblastoma tumorspheres","volume":"149","author":"Park","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101433_bib0032","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF01974011","article-title":"Inhibition of ferrochelatase and accumulation of porphyrins in mouse hepatocyte cultures exposed to porphyrinogenic chemicals","volume":"66","author":"Brady","year":"1992","journal-title":"Arch. Toxicol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101433_bib0033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1139\/y95-234","article-title":"Cytochrome P450 and its interactions with the heme biosynthetic pathway","volume":"74","author":"De Matteis","year":"1996","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101433_bib0034","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0923-1811(98)00073-5","article-title":"Alteration of mRNA levels of delta-aminolevulinic acid synthase, ferrochelatase and heme oxygenase-1 in griseofulvin induced protoporphyria mice","volume":"19","author":"Inafuku","year":"1999","journal-title":"J. Dermatol. Sci."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101433_bib0035","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1089\/pho.2006.24.186","article-title":"Griseofulvin enhances the effect of aminolevulinic acid-based photodynamic therapy in vitro","volume":"24","author":"Nomura","year":"2006","journal-title":"Photomed. Laser Surg."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101433_bib0036","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.21873\/anticanres.11566","article-title":"Griseofulvin efficiently induces apoptosis in in vitro treatment of lymphoma and multiple myeloma","volume":"37","author":"Schmeel","year":"2017","journal-title":"Anticancer Res."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101433_bib0037","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s10495-012-0800-8","article-title":"The anti-mitotic drug griseofulvin induces apoptosis of human germ cell tumor cells through a connexin 43-dependent molecular mechanism","volume":"18","author":"Mauro","year":"2013","journal-title":"Apoptosis"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101433_bib0038","first-page":"13","article-title":"Cytoskeleton structure and dynamic behaviour: quick excursus from basic molecular mechanisms to some implications in cancer chemotherapy","volume":"13","author":"Alberti","year":"2009","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101433_bib0039","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1083\/jcb.104.2.289","article-title":"Microtubules containing acetylated alpha-tubulin in mammalian cells in culture","volume":"104","author":"Piperno","year":"1987","journal-title":"J. Cell Biol."},{"issue":"6887","key":"10.1016\/j.ctarc.2026.101433_bib0040","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/417455a","article-title":"HDAC6 is a microtubule-associated deacetylase","volume":"417","author":"Hubbert","year":"2002","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101433_bib0041","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S1097-2765(03)00038-8","article-title":"The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase","volume":"11","author":"North","year":"2003","journal-title":"Mol. Cell"}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226003436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226003436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:39:56Z","timestamp":1791488396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294226003436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":41,"alternative-id":["S2468294226003436"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101433","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Griseofulvin as a dual-action agent against glioblastoma: anti-tumor effect and enhancement of 5-ALA photodynamic diagnosis in stem-like cells","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101433","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101433"}}